| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9149(88)90282-2 |
| P698 | PubMed publication ID | 3143257 |
| P50 | author | Harry J. G. M. Crijns | Q110902217 |
| P2093 | author name string | K I Lie | |
| I C van Gelder | |||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ventricular tachycardia | Q56002 |
| P304 | page(s) | 1303-1306 | |
| P577 | publication date | 1988-12-01 | |
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment | |
| P478 | volume | 62 |
| Q22306351 | ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation |
| Q34093427 | ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Co |
| Q41564201 | Adverse effects of class I antiarrhythmic drugs |
| Q42141607 | Alternating bizarrely-shaped broad QRS complex tachycardia. What is the mechanism? |
| Q33145007 | Antiarrhythmic drug initiation in patients with atrial fibrillation |
| Q36774765 | Antiarrhythmic drug treatment: need for continuous vigilance |
| Q34012641 | Antiarrhythmic drugs: from mechanisms to clinical practice |
| Q74315489 | Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators |
| Q73576681 | Atrial defibrillation at the millennium: new challenges for evolving technology |
| Q37368168 | Clinical pharmacokinetics of propafenone |
| Q73200648 | Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation. PARSIFAL Study Group |
| Q50753311 | Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens. |
| Q44616001 | Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation |
| Q43152056 | Flecainide for cardioversion in patients at elevated cardiovascular risk and persistent atrial fibrillation: a prospective observational study |
| Q33655232 | In-hospital approach to newly recognized atrial fibrillation |
| Q40834298 | Is there a future for antiarrhythmic drug therapy? |
| Q87420136 | Lacosamide-induced atrial tachycardia in a child with hypoplastic left-heart syndrome: the importance of assessing additional proarrhythmic risks |
| Q46631229 | Long-term efficacy of hybrid pharmacologic and ablation therapy in patients with pilsicainide-induced atrial flutter. |
| Q34778156 | Maintaining stability of sinus rhythm in atrial fibrillation: antiarrhythmic drugs versus ablation |
| Q34752325 | Mechanisms and management of proarrhythmia |
| Q35096843 | Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials |
| Q34482842 | Pharmacology and Toxicology of Nav1.5-Class 1 anti-arrhythmic drugs |
| Q40688560 | Predictors of atrial flutter with 1:1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias |
| Q77535837 | Proarrhythmia |
| Q42556865 | Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group |
| Q74611460 | Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation |
| Q38936964 | Rate control in atrial fibrillation |
| Q41111464 | Rate control versus electrical cardioversion for atrial fibrillation: A randomised comparison of two treatment strategies concerning morbidity, mortality, quality of life and cost-benefit - the RACE study design |
| Q70139350 | Regular ventricular rhythms in patients with symptomatic paroxysmal atrial fibrillation |
| Q34334154 | Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology |
| Q41664554 | The medical management of atrial fibrillation. |
| Q58716724 | Time-dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses |
| Q34505579 | Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation |
| Q86502279 | Wide complex tachycardia in the presence of class I antiarrhythmic agents: a diagnostic challenge |
Search more.